Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade

DCP-001 is a cell-based cancer vaccine generated by differentiation and maturation of cells from the human DCOne myeloid leukemic cell line. This results in a vaccine comprising a broad array of endogenous tumor antigens combined with a mature dendritic cell (mDC) costimulatory profile, functioning...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haoxiao Zuo, Marie-José C. van Lierop, Jorn Kaspers, Remco Bos, Anneke Reurs, Saheli Sarkar, Tania Konry, Alwin Kamermans, Gijs Kooij, Helga E. de Vries, Tanja D. de Gruijl, Alex Karlsson-Parra, Erik H. Manting, Ada M. Kruisbeek, Satwinder Kaur Singh
Format:	article
Language:	EN
Published:	MDPI AG 2021
Subjects:	DCP-001 DCOne allogeneic dendritic cell cell-based vaccine acute myeloid leukemia Biology (General) QH301-705.5
Online Access:	https://doaj.org/article/467c11dcb8d4413a8aaeb2c376d6e894
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade

Similar Items